174 related articles for article (PubMed ID: 23469311)
21. A CATT negative result after treatment for human African trypanosomiasis is no indication for cure.
Lejon V; Ngoyi DM; Boelaert M; Büscher P
PLoS Negl Trop Dis; 2010 Jan; 4(1):e590. PubMed ID: 20126270
[TBL] [Abstract][Full Text] [Related]
22. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
23. Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection.
Ngay Lukusa I; Van Reet N; Mumba Ngoyi D; Miaka EM; Masumu J; Patient Pyana P; Mutombo W; Ngolo D; Kobo V; Akwaso F; Ilunga M; Kaninda L; Mutanda S; Muamba DM; Valverde Mordt O; Tarral A; Rembry S; Büscher P; Lejon V
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009739. PubMed ID: 34534223
[TBL] [Abstract][Full Text] [Related]
24. Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness.
Jansson-Löfmark R; Na-Bangchang K; Björkman S; Doua F; Ashton M
Antimicrob Agents Chemother; 2015 Feb; 59(2):1299-307. PubMed ID: 25512417
[TBL] [Abstract][Full Text] [Related]
25. Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire.
Jamonneau V; Solano P; Garcia A; Lejon V; Djé N; Miezan TW; N'Guessan P; Cuny G; Büscher P
Trop Med Int Health; 2003 Jul; 8(7):589-94. PubMed ID: 12828540
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
27. [Follow - up prognostic study on two imported patients with human African trypanosomiasis].
Li YY; Chen XL; Liu Q; Wang XY; Chen MX; Liu Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Jun; 33(3):293-296. PubMed ID: 34286532
[TBL] [Abstract][Full Text] [Related]
28. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire.
Pépin J; Milord F; Meurice F; Ethier L; Loko L; Mpia B
Trans R Soc Trop Med Hyg; 1992; 86(3):254-6. PubMed ID: 1412646
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis.
Doua F; Miezan TW; Sanon Singaro JR; Boa Yapo F; Baltz T
Am J Trop Med Hyg; 1996 Dec; 55(6):586-8. PubMed ID: 9025682
[TBL] [Abstract][Full Text] [Related]
30. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
Kennedy PGE; Rodgers J
Front Immunol; 2019; 10():39. PubMed ID: 30740102
[TBL] [Abstract][Full Text] [Related]
31. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
32. 3 Tesla serial magnetic resonance imaging of human African trypanosomiasis (Trypanosoma brucei gambiense) and review of the literature.
Boukobza M; Lariven S; Houze S; Laissy JP
Rev Neurol (Paris); 2021 Nov; 177(9):1176-1182. PubMed ID: 33648780
[TBL] [Abstract][Full Text] [Related]
33. Stage determination and follow-up in sleeping sickness.
Lejon V; Buscher P
Med Trop (Mars); 2001; 61(4-5):355-60. PubMed ID: 11803826
[TBL] [Abstract][Full Text] [Related]
34. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V
Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944
[TBL] [Abstract][Full Text] [Related]
35. The phenomenon of treatment failures in Human African Trypanosomiasis.
Brun R; Schumacher R; Schmid C; Kunz C; Burri C
Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
[TBL] [Abstract][Full Text] [Related]
36. Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNA.
Ilboudo H; Camara O; Ravel S; Bucheton B; Lejon V; Camara M; Kaboré J; Jamonneau V; Deborggraeve S
J Infect Dis; 2015 Dec; 212(12):1996-8. PubMed ID: 26080371
[TBL] [Abstract][Full Text] [Related]
37. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.
Pépin J; Khonde N
Trans R Soc Trop Med Hyg; 1996; 90(2):183-6. PubMed ID: 8761585
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
Milord F; Pépin J; Loko L; Ethier L; Mpia B
Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
[TBL] [Abstract][Full Text] [Related]
39. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire.
Pepin J; Milord F; Mpia B; Meurice F; Ethier L; DeGroof D; Bruneel H
Trans R Soc Trop Med Hyg; 1989; 83(4):514-7. PubMed ID: 2694491
[TBL] [Abstract][Full Text] [Related]
40. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction.
Kyambadde JW; Enyaru JC; Matovu E; Odiit M; Carasco JF
Bull World Health Organ; 2000; 78(1):119-24. PubMed ID: 10686746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
